18:18:02 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-11-07 Kvartalsrapport 2024-Q3
2024-08-21 Kvartalsrapport 2024-Q2
2024-05-16 X-dag ordinarie utdelning STENO 0.00 DKK
2024-05-15 Årsstämma 2024
2024-05-02 Kvartalsrapport 2024-Q1
2024-02-22 Bokslutskommuniké 2023
2024-02-05 Extra Bolagsstämma 2024
2023-11-09 Kvartalsrapport 2023-Q3
2023-08-17 Kvartalsrapport 2023-Q2
2023-06-20 Kvartalsrapport 2023-Q1
2023-06-13 Extra Bolagsstämma 2023
2023-05-22 X-dag ordinarie utdelning STENO 0.00 DKK
2023-02-23 Bokslutskommuniké 2022
2022-11-18 Extra Bolagsstämma 2022
2022-11-09 Kvartalsrapport 2022-Q3
2022-08-18 Kvartalsrapport 2022-Q2
2022-05-20 X-dag ordinarie utdelning STENO 0.00 DKK
2022-05-19 Årsstämma 2022
2022-05-05 Kvartalsrapport 2022-Q1
2022-02-24 Bokslutskommuniké 2021
2021-11-04 Kvartalsrapport 2021-Q3
2021-08-19 Kvartalsrapport 2021-Q2
2021-05-21 X-dag ordinarie utdelning STENO 0.00 DKK
2021-05-20 Årsstämma 2021
2021-05-06 Kvartalsrapport 2021-Q1
2021-02-25 Bokslutskommuniké 2020
2020-11-05 Kvartalsrapport 2020-Q3
2020-08-20 Kvartalsrapport 2020-Q2
2020-05-15 X-dag ordinarie utdelning STENO 0.00 DKK
2020-05-14 Årsstämma 2020
2020-05-07 Kvartalsrapport 2020-Q1
2020-02-26 Bokslutskommuniké 2019
2019-11-06 Kvartalsrapport 2019-Q3
2019-08-20 Kvartalsrapport 2019-Q2
2019-05-07 Kvartalsrapport 2019-Q1
2019-02-21 Bokslutskommuniké 2018

Beskrivning

LandDanmark
ListaFirst North Denmark
SektorHälsovård
IndustriLäkemedel & Handel
Stenocare är verksamt inom hälsovårdsindustrin. Bolaget är specialiserat inom utveckling av medicinsk cannabis. Stenocare är en av de första aktören att ha påbörjat försäljning av medicinska cannabisoljor i Danmark. Bolaget kommer framöver även vända sig till övriga europeiska marknader med sitt produktutbud. Stenocares huvudkontor ligger i Randers.
2023-12-21 17:26:58

STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER:  STENO

This information is information that STENOCARE A/S is obliged to publish in accordance with the EU Market Abuse Regulation. The information was provided by the contact person below for publication on Dec 21, 2023.

The three founders of STENOCARE A/S ("Stenocare") are merging their individual Holding Companies into a new Holding company named "SC Founders Holding ApS". The total ownership of STENOCARE shares is unchanged.

Change from: The three Stenocare founders have owned their Stenocare shares in three Holding companies since the Stenocare initial Public Offering (IPO) in October 2018. The three Holding companies are:
  • Steno Group ApS, owning 1.671.697 Stenocare shares
  • MS Kjær Holding ApS, owning 1.630.103 Stenocare shares
  • Prana Holding ApS, owning 1.569.222 Stenocare shares

The total holdings for these three Holding companies are 4.871.022 Stenocare shares, This is equal to 32,25% of total shares before completion of the TO1 Warrant transaction and Directed Issues announced December 19, 2023.

Change to: The three founders have merged all their prior holdings of Stenocare shares into a new Holding company named "SC Founders Holding ApS", that owns a total of 4.871.022 Stenocare shares. This was equal to 32,25% of total shares before completion of the TO1 Warrant transaction and Directed Issues announced December 19, 2023. After the successful completion of the Directed Issues announced December 19, 2023 and the TO1 Warrant transaction announced December 21, 2023 - the new "SC Founders Holding ApS" own 26,50% of total shares. The three founders' shareholdings are carried into SC Founders Holding Aps with unchanged individual ownership of Stenocare shares. The only activity and objective of SC Founders Aps is to own shares in Stenocare.
  • SC Founders Holding ApS, owning 4.871.022 Stenocare shares

The two Stenocare founders, that announced December 19 their participation in the Directed Issue, have made that investment via their personal accounts. Therefore, this is not included in the SC Founders Holding Aps ownership.